Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Cholecystokinin receptor type A | ||
Ligand | BDBM50045809 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEBML_49729 | ||
Ki | 1540±n/a nM | ||
Citation | Blommaert, AG; Weng, JH; Dorville, A; McCort, I; Ducos, B; Durieux, C; Roques, BP Cholecystokinin peptidomimetics as selective CCK-B antagonists: design, synthesis, and in vitro and in vivo biochemical properties. J Med Chem36:2868-77 (1993) [PubMed] | ||
More Info.: | Get all data from this article, Assay Method | ||
Cholecystokinin receptor type A | |||
Name: | Cholecystokinin receptor type A | ||
Synonyms: | CCK-A receptor | CCK-AR | CCK1-R | CCKAR | CCKAR_CAVPO | Cholecystokinin A receptor | Cholecystokinin receptor type A | Cholecystokinin-1 receptor | ||
Type: | n/a | ||
Mol. Mass.: | 48229.77 | ||
Organism: | Cavia porcellus | ||
Description: | n/a | ||
Residue: | 430 | ||
Sequence: |
| ||
BDBM50045809 | |||
n/a | |||
Name | BDBM50045809 | ||
Synonyms: | CHEMBL316462 | [1-[2-(3,4-Dichloro-phenyl)-ethylcarbamoyl]-2-(1H-indol-3-yl)-1-methyl-ethyl]-carbamic acid adamantan-2-yl ester | ||
Type | Small organic molecule | ||
Emp. Form. | C31H35Cl2N3O3 | ||
Mol. Mass. | 568.534 | ||
SMILES | CC(Cc1c[nH]c2ccccc12)(NC(=O)OC1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2)C(=O)NCCc1ccc(Cl)c(Cl)c1 |wU:21.23,19.27,17.19,wD:23.24,TLB:15:16:18:21.25.20,THB:22:23:18:21.25.20,22:21:18:16.23.24,(13.49,-10.17,;12.16,-10.95,;10.83,-11.72,;10.83,-13.28,;11.74,-14.51,;10.85,-15.77,;9.38,-15.31,;8.03,-16.08,;6.7,-15.31,;6.7,-13.75,;8.03,-12.98,;9.36,-13.75,;10.66,-10.55,;9.32,-9.78,;8.22,-10.86,;8.92,-8.29,;7.44,-7.89,;5.69,-7.89,;4.63,-8.94,;3.34,-8.29,;2.8,-6.88,;3.9,-5.83,;5.54,-5.68,;6.11,-7.09,;4.95,-8.2,;5.13,-6.6,;13.49,-11.72,;13.49,-13.25,;15.03,-11.71,;15.8,-10.38,;17.34,-10.38,;18.11,-9.04,;17.32,-7.71,;18.09,-6.39,;19.63,-6.38,;20.4,-5.05,;20.42,-7.71,;21.96,-7.71,;19.63,-9.05,)| | ||
Structure |